A Sanofi subsidiary has claimed FDA approval for the first biosimilar ... which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.

Lantus sales are dropping fast because of the competition ... the performance of the established rivals. The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September ...

The FDA approved 3 mL single-patient-use prefilled pen and 10 mL multiple-dose vial versions of the drug. Merilog is the first rapid-acting insulin biosimilar to be approved by the agency.

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

The approval is based on positive 1-year data from the phase 3 Pavilion study. This is Susvimo’s third FDA-approved indication. Perspective from David A. Eichenbaum, MD The FDA approved Susvimo ...

Novavax (NVAX) shares soared 25% at the opening bell Monday after the Food and Drug Administration (FDA) approved its new COVID-19 vaccine. The drugmaker said the FDA approved its Biologics ...